- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | INIFY LABORATORIES AB: Gastrointestinal Service Launch and Progress in the UK Expansion | 1 | Cision News | ||
| Mi | INIFY Laboratories AB: Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics | 3 | Oslo Børs | ||
| 30.01. | INIFY LABORATORIES AB: Correction: Inify Laboratories - mandatory notification of trade | 1 | Cision News | ||
| 27.01. | INIFY Laboratories AB: Inify Laboratories - mandatory notification of trade | - | Oslo Børs | ||
| 27.01. | INIFY Laboratories AB: Inify Laboratories - Final Results of the Repair Issue | - | Oslo Børs | ||
| 12.01. | INIFY LABORATORIES AB: Inify Laboratories - Commencement of subscription period for Repair Issue | 1 | Cision News | ||
| 19.12.25 | INIFY Laboratories AB: Inify Laboratories announces final results of fully guaranteed private placement | 1 | Oslo Børs | ||
| INIFY LABORATORIES Aktie jetzt für 0€ handeln | |||||
| 19.12.25 | INIFY Laboratories AB: Inify Laboratories - mandatory notification of trade | 1 | Oslo Børs | ||
| 17.12.25 | INIFY Laboratories AB: Inify Laboratories: Key information regarding Repair Issue | 1 | Oslo Børs | ||
| 17.12.25 | INIFY LABORATORIES AB: Inify Laboratories announces preliminary results of fully guaranteed private placement | 1 | Cision News | ||
| 16.12.25 | INIFY Laboratories AB: Inify Laboratories - notification of trade | 2 | Oslo Børs | ||
| 16.12.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 16.12.2025 | 504 | Xetra Newsboard | Das Instrument 48Z0 US4432012072 HOWMET AEROSPACE 3,75 PFD EQUITY wird cum Kapitalmassnahme gehandelt am 16.12.2025 und ex Kapitalmassnahme am 17.12.2025 The instrument 48Z0 US4432012072 HOWMET AEROSPACE... ► Artikel lesen | |
| 09.12.25 | INIFY LABORATORIES AB: Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue | 1 | Cision News | ||
| 04.12.25 | Bulletin from the extraordinary general meeting of Inify Laboratories AB | 1 | Cision News | ||
| 03.12.25 | INIFY LABORATORIES AB: Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue | 1 | Cision News | ||
| 28.11.25 | INIFY Laboratories AB: Financial calendar | 2 | Oslo Børs | ||
| 12.11.25 | INIFY Laboratories AB: Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025 | 1 | Oslo Børs | ||
| 12.11.25 | INIFY Laboratories AB: Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million | - | Oslo Børs | ||
| 29.10.25 | INIFY Laboratories AB: Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 | 2 | Oslo Børs | ||
| 29.10.25 | INIFY LABORATORIES AB: Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 | 2 | Cision News |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GENEDX | 74,20 | -6,98 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| PROGYNY | 17,600 | 0,00 % | KeyBanc senkt Kursziel für Progyny-Aktie aufgrund konservativer Schätzungen | ||
| PROCEPT BIOROBOTICS | 25,920 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,570 | +0,46 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,640 | +2,19 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| HEARTFLOW | 24,050 | +4,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,020 | +1,22 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 7,430 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,150 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| CLEARPOINT NEURO | 9,805 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,330 | +1,23 % | DAX-Check LIVE: Aixtron, CEWE, Elmos, FMC, MTU, SFC Energy im Fokus | Neue Zolldrohungen aus Washington haben den deutschen Aktienmarkt zum Wochenstart unter Druck gesetzt. Der DAX fiel 1,06 Prozent auf 24.991 Punkte und rutschte damit wieder unter die Marke von 25.000... ► Artikel lesen | |
| MIMEDX | 4,880 | -0,41 % | MiMedx Group, Inc: MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results | Net Sales Grew 27% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter GAAP Net Income and Earnings Per Share were $15 million and $0.10, Respectively Fourth Quarter Adjusted... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,260 | -0,27 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| FRESENIUS | 49,630 | -2,26 % | Märkte am Morgen: Warner Bros-Übernahme, PayPal, AMC Entertainment, Fresenius, Jost Werke | Der DAX ist nach dem schwachen Handel am Montag auch gestern nicht in die Gänge gekommen. Letzten Endes ging der DAX 0,02 Prozent tiefer bei 24.986 Punkten aus dem Handel. Heute könnte er die Rückkehr... ► Artikel lesen | |
| BILLIONTOONE | 78,75 | +3,93 % | BillionToOne, Inc.: BillionToOne Provides Guidance for 2026 | MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen |
Das Unternehmen INIFY LABORATORIES AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -40,33 % bei einem Aktienkurs von 0,179 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INIFY LABORATORIES AB finden Sie auf Wallstreet Online.